Meeting
2022 ASCO Quality Care Symposium
Clinical uptake of precision medicine advances in NSCLC: A case study in RET fusions.
Authors
Krista Marcello
Clinical Care Options, LLC, Reston, VA
Krista Marcello, Taofeek K. Owonikoko, Karen L. Reckamp, Laura J. Tafe, Rachael Andrie, Kevin Obholz
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A
Track
Cost, Value, and Policy,Health Care Access, Equity, and Disparities,Patient Experience
Sub Track
Guideline-Concordant Care Initiatives
Citation
J Clin Oncol 40, 2022 (suppl 28; abstr 32)
DOI
10.1200/JCO.2022.40.28_suppl.032
Abstract #
32
Poster Bd #
B2
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
Clinical outcomes among patients with advanced non-small cell lung cancer who received targeted therapy in a real-world setting.
First Author: Mo Yang
Poster
2023 ASCO Annual Meeting
Caveat emptor: A descriptive analysis of guideline-recommended biomarker inclusion in targeted NGS panels for metastatic non-small cell lung cancer (mNSCLC).
First Author: John Leonard Fox
Poster
2023 ASCO Annual Meeting
A master screening study to determine biomarker status and trial eligibility for patients with malignant tumors.
First Author: Benjamin J. Solomon
Poster
2022 ASCO Annual Meeting
Optimizing supportive care for patients with metastatic lung cancer in the era of precision oncology.
First Author: Kelly Hsu